selective vulnerability < selegiline < selenium

Facettes :

List of bibliographic references indexed by selegiline

Number of relevant bibliographic references: 11.

Ident.	Authors (with country if any)	Title
000F56 (2007)	V. Pursiainen [Finlande] ; T. J. Korpelainen [Finlande] ; H. T. Haapaniemi [Finlande] ; A. K. Sotaniemi [Finlande] ; V. V. Myllyl [Finlande]	Selegiline and blood pressure in patients with Parkinson's disease
001008 (2007)	Fernandez [États-Unis] ; Chen [États-Unis]	Monoamine Oxidase‐B Inhibition in the Treatment of Parkinson's Disease
001843 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
001A73 (2001)	D. A. M. C. Van De Vijver [Pays-Bas] ; R. A. C. Roos [Pays-Bas] ; P. A. F. Jansen [Pays-Bas] ; A. J. Porsius [Pays-Bas] ; A. De Boer [Pays-Bas]	Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records
001D39 (1999)	H. Przuntek ; B. Conrad [Allemagne] ; J. Dichgans ; P. H. Kraus ; P. Krauseneck ; G. Pergande ; U. Rinne [Finlande] ; K. Schimrigk ; J. Schnitker ; H. P. Vogel [Allemagne]	SELEDO: a 5‐y‐ear long‐term trial on the effect of selegiline in early parkinsonian patients treated with levodopa
001F92 (1997)	V. V. Myllyl [Finlande] ; K. A. Sotaniemi [Finlande] ; P. Hakulinen [Finlande] ; O. M Ki-Lkola [Finlande] ; E. H. Heinonen [Finlande]	Selegiline as the primary treatment of Parkinson's disease — a long‐term double‐blind study
002682 (1991)	H. Allain [France] ; J. Cougnard [France] ; H-C. Neukirch [France]	Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMT)
002692 (1991)	J. O. Rinne [Finlande]	Nigral degeneration in Parkinson's disease in relation to clinical features
002693 (1991)	U. K. Rinne [Finlande]	New strategies in the treatment of early Parkinson's disease
002703 (1991)	A. Lieberman [États-Unis] ; E. Fazzini [États-Unis]	Experience with selegiline and levodopa in advanced Parkinson's disease
002725 (1991)	E. H. Heinonen [Finlande] ; R. Lammintausta [Finlande]	A review of the pharmacology of selegiline

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "selegiline" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "selegiline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    selegiline
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024